FTRE
FTRE
NASDAQ · Life Sciences Tools & Services

Fortrea Holdings Inc

$19.93
-0.35 (-1.73%)
As of Sep 20, 10:12 PM ET ·
Analyst Consensus
Buy
17
Analysts
High
Coverage
Buy 10 59%
Hold 6 35%
Sell 1 6%
Price Target
Analyst Price Target +134.9% upside
Low Target $29.35
Average Target $46.82
High Target $58.56
Current Price $19.93
Current
$19.93
Target
$46.82
$29.35 $46.82 avg $58.56
Scenario Analysis
Bear Case
$29.35
47.3%
Low target
Base Case
$46.82
+134.9%
Avg target
Bull Case
$58.56
+193.8%
High target
Risk/Reward
4.1x
Highly favorable
Price in Context
52-Week High
$21.39
-6.8% from high
52-Week Low
$8.31
+140.0% from low
Target vs 52W High
$46.82
+118.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 36 81% $369.21 -44.5%
DHR
Danaher Corp
Strong Buy 32 84% $158.11 -28.6%
IQV
Iqvia Holdings Inc
Strong Buy 28 82% $82.96 -69.0%
A
Agilent Technologies Inc
Strong Buy 30 77% $64.69 -60.9%
WAT
Waters Corp
Buy 31 65% $189.60 -54.9%
ILMN
Illumina Inc
Buy 28 57% $169.36 -33.7%
MTD
Mettler-Toledo International
Hold 19 53% $170.43 -88.6%
WST
West Pharmaceutical Services
Strong Buy 23 91% $136.24 -63.8%